Contact this trialFirst, we need to learn more about you.
Sphingosine-1-phosphate receptor modulator
Ponesimod 10 mg +2 More for Multiple Sclerosis
Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial will study the long-term effects of ponesimod, a drug used to treat relapsing-remitting multiple sclerosis.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.